Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan 20;2(1):00081-2015.
doi: 10.1183/23120541.00081-2015. eCollection 2016 Jan.

The EMBARC European Bronchiectasis Registry: protocol for an international observational study

Affiliations

The EMBARC European Bronchiectasis Registry: protocol for an international observational study

James D Chalmers et al. ERJ Open Res. .

Abstract

Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no approved therapies and few large-scale, representative epidemiological studies. The EMBARC (European Multicentre Bronchiectasis Audit and Research Collaboration) registry is a prospective, pan-European observational study of patients with bronchiectasis. The inclusion criterion is a primary clinical diagnosis of bronchiectasis consisting of: 1) a clinical history consistent with bronchiectasis; and 2) computed tomography demonstrating bronchiectasis. Core exclusion criteria are: 1) bronchiectasis due to known cystic fibrosis; 2) age <18 years; and 3) patients who are unable or unwilling to provide informed consent. The study aims to enrol 1000 patients by April 2016 across at least 20 European countries, and 10 000 patients by March 2020. Patients will undergo a comprehensive baseline assessment and will be followed up annually for up to 5 years with the goal of providing high-quality longitudinal data on outcomes, treatment patterns and quality of life. Data from the registry will be available in the form of annual reports. and will be disseminated in conference presentations and peer-reviewed publications. The European Bronchiectasis Registry aims to make a major contribution to understanding the natural history of the disease, as well as guiding evidence-based decision making and facilitating large randomised controlled trials.

PubMed Disclaimer

Conflict of interest statement

S. Masefield is an employee of the European Respiratory Society. Disclosures can be found alongside this article at openres.ersjournals.com

Figures

FIGURE 1
FIGURE 1
Study flowchart. CT: computed tomography.
FIGURE 2
FIGURE 2
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) data collection platform. Image courtesy of EMBARC and the Health Informatics Centre (University of Dundee, Dundee, UK).
FIGURE 3
FIGURE 3
Distribution of EMBARC (European Multicentre Bronchiectasis Audit and Research Collaboration) sites across Europe.

References

    1. Keistinen T, Savnajakangas O, Tuuponen T, et al. . Bronchiectasis: an orphan disease with a poorly understood prognosis. Eur Respir J 1997; 10: 2784–2787. - PubMed
    1. Elborn JS. Bronchiectasis. In: Gibson GJ, Loddenkemper R, Sibille Y, et al., eds. The European Lung White Book. Sheffield, European Respiratory Society, 2013.
    1. Chalmers JD, Aliberti S, Blasi F. Bronchiectasis in adults. Eur Respir J 2015; 45: 1446–1462. - PubMed
    1. Kelly MG, Murphy S, Elborn JS. Bronchiectasis in secondary care: a comprehensive profile of a neglected disease. Eur J Intern Med 2003; 14: 488–492. - PubMed
    1. Chalmers JD, Loebinger M, Aliberti S. Challenges in the development of new therapies for bronchiectasis. Curr Opin Pharmacother 2015; 16: 833–850. - PubMed